This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: The Institute of Cancer Research: Royal Cancer Hospital, Oxford University Innovation Ltd. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxford, GB (2023 - 2024)
- Headington, GB (2024)
Company Filing History:


Years Active: 2023-2024
Title: Terrence Rabbitts: Innovator in Pharmaceutical Compounds
Introduction
Terrence Rabbitts is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative disorders, including cancer. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Terrence's latest patents focus on innovative compounds of Formula I, which are designed for use in pharmaceutical compositions. These compounds are intended for the treatment of proliferative disorders, such as cancer, and other diseases where the inhibition of a RAS-effector protein-protein interaction is crucial. His research emphasizes the importance of these compounds in addressing disorders associated with mutant RAS, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Terrence has worked with esteemed institutions such as the Institute of Cancer Research: Royal Cancer Hospital and Oxford University Innovation Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Terrence has collaborated with notable colleagues, including Camilo Quevedo and Abimael Cruz. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Terrence Rabbitts stands out as an influential inventor in the realm of pharmaceutical compounds. His dedication to developing treatments for serious health conditions reflects his passion for innovation and the betterment of society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile